Evaluation of a liver micronucleus assay with 12 chemicals using young rats (II): a study by the Collaborative Study Group for the Micronucleus Test/Japanese Environmental Mutagen Society-Mammalian Mutagenicity Study Group.

The partial hepatectomy method, co-treatment method with mitogens and an in vivo/in vitro assay method have been reported as in vivo liver micronucleus (MN) assays. These methods have disadvantages with respect to widespread use as an in vivo assay, i.e. they are time consuming, labour intensive and there is the possibility of interaction with the mitogens used. Therefore, we have attempted to develop a new method to overcome these disadvantages. The assay as described herein utilises the autonomous proliferation of hepatocytes of young rats. Nine chemicals have been evaluated using this method thus far. We have also assessed the sensitivity and detectability according to the following methods. A liver MN assay was performed in two strains of young rats using one or two doses of 12 chemicals to investigate the inducibility of micronucleated hepatocytes. For some of the chemicals, a peripheral blood MN assay was performed concurrently in the same animals. The following chemicals were used: diethylnitrosamine (DEN), 2-acetylaminofluorene (2AAF), 2,4-diaminotoluene (2,4-DAT), quinoline, p-dimethylaminoazobenzene (DAB), dimethylnitrosamine (DMN), ethylmethanesulphonate, 5-fluorouracil, mitomycin C (MMC), 1,2-dimethylhydrazine.2HCl, cyclophosphamide and 2,4-dinitrotoluene (2,4-DNT). The rodent hepatocarcinogens, quinoline, DAB and DMN showed positive responses in previous assays. The results of the present assay revealed new positive responses for single doses of 2AAF, 2,4-DAT, MMC, 1,2-dimethylhydrazine.2HCl and 2,4-DNT. These chemicals are known rodent hepatocarcinogens, whose clastogenicity is believed to be related to the formation of reactive metabolites generated through enzymatic activation, or the chemicals act directly. Two doses of 2AAF and DMN appeared to be more effective than a single dose in terms of MN induction. Although there were quantitative differences in the incidences of MNs, both strains of rat (F344 and SD) responded positively after treatment with DEN, DMN, 2,4-DAT, DAB, quinoline and 2AAF, suggesting that both strains are appropriate for the assay. Based on these results, it is concluded that this technique could be effective for detecting chemical clastogenicity in hepatocytes in vivo.

[1]  Stephen D Dertinger,et al.  In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test. , 2007, Mutation research.

[2]  Saralees Nadarajah,et al.  Letter to the editor , 2007, Int. Trans. Oper. Res..

[3]  Takayoshi Kobayashi,et al.  Genotoxicity studies OF p-dimethylaminoazobenzene (DAB). , 2006, The Journal of toxicological sciences.

[4]  Y. Takagi,et al.  Further evaluation of the skin micronucleus test: results obtained using 10 polycyclic aromatic hydrocarbons. , 2005, Mutation research.

[5]  Takayoshi Suzuki,et al.  Evaluation of liver and peripheral blood micronucleus assays with 9 chemicals using young rats. A study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)-Mammalian Mutagenicity Study Group (MMS). , 2005, Mutation research.

[6]  D. Lorke.  A new approach to practical acute toxicity testing , 1983, Archives of Toxicology.

[7]  H. Suzuki,et al.  A liver micronucleus assay using young rats exposed to diethylnitrosamine: methodological establishment and evaluation , 2004, Cytogenetic and Genome Research.

[8]  M. Cimino,et al.  Genotoxicity risk assessment: a proposed classification strategy. , 2002, Mutation research.

[9]  M. Hayashi,et al.  Collaborative validation study of the in vivo micronucleus test using mouse colonic epithelial cells. , 2002, Mutation research.

[10]  M. Hayashi,et al.  Further evaluation of an in vivo micronucleus test on rat and mouse skin: results with five skin carcinogens. , 2002, Mutation research.

[11]  M. Hayashi,et al.  Study of a rat skin in vivo micronucleus test: data generated by mitomycin C and methyl methanesulfonate. , 1999, Mutation research.

[12]  Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, 17-24 February 1998. , 1999, IARC monographs on the evaluation of carcinogenic risks to humans.

[13]  Makoto Hayashi,et al.  Evaluation of the rat micronucleus test with bone marrow and peripheral blood: Summary of the 9th collaborative study by CSGMT/JEMS·MMS , 1998, Environmental and molecular mutagenesis.

[14]  Y. Sasaki,et al.  Simple detection of chemical mutagens by the alkaline single-cell gel electrophoresis (Comet) assay in multiple mouse organs (liver, lung, spleen, kidney, and bone marrow). , 1997, Mutation research.

[15]  T Sofuni,et al.  Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group. , 1997, Mutation research.

[16]  M. Garriott,et al.  An evaluation of micronucleus induction in bone marrow and in hepatocytes isolated from collagenase perfused liver or from formalin‐fixed liver using four‐week‐old rats treated with known clastogens , 1997, Environmental and molecular mutagenesis.

[17]  V. Zhurkov,et al.  Selective induction of micronuclei in the rat/mouse colon and liver by 1,2-dimethylhydrazine: a seven-tissue comparative study. , 1996, Mutation research.

[18]  G. Williams,et al.  2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation. , 1996, Pharmacology & therapeutics.

[19]  Printing processes and printing inks, carbon black and some nitro compounds. Lyon, France, 10-17 October 1995. , 1996, IARC monographs on the evaluation of carcinogenic risks to humans.

[20]  H. Matthews,et al.  Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens. , 1995, Toxicology letters.

[21]  K. Yoshikawa.  EARLY INDUCTION OF IN VIVO-IN VITRO HEPATOCYTE REPLICATIVE DNA SYNTHESIS (RDS) BY NONGENOTOXIC AND GENOTOXIC HEPATOCARCINOGENS IN MALE F334 RATS AND B6C3F1 MICE , 1995 .

[22]  K. Müller,et al.  An assessment of the in vitro hepatocyte micronucleus assay. , 1993, Mutation research.

[23]  T. Sofuni,et al.  The concomitant detection of gene mutation and micronucleus induction by mitomycin C in vivo using lacZ transgenic mice. , 1993, Mutation research.

[24]  R Kato,et al.  Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. , 1992, Toxicology letters.

[25]  B. Dash,et al.  Genotoxicity of 'gudakhu', a tobacco preparation. I. In mice in vivo. , 1992, Mutation research.

[26]  M. Armstrong,et al.  A quantitative assessment of the cytotoxicity associated with chromosomal aberration detection in Chinese hamster ovary cells. , 1992, Mutation research.

[27]  C. Westmoreland,et al.  Evaluation of the in vivo genotoxicity of the structural analogues 2,6-diaminotoluene and 2,4-diaminotoluene using the rat micronucleus test and rat liver UDS assay. , 1991, Carcinogenesis.

[28]  P. Harbach,et al.  Strain differences in in vitro rat hepatocyte unscheduled DNA synthesis (UDS): effect of UV is independent of strain while increased sensitivity is apparent using Fischer-344 instead of Sprague-Dawley rats. , 1991, Mutation research.

[29]  T. Sofuni,et al.  The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. , 1990, Mutation research.

[30]  E. Fournier,et al.  In vivo micronucleus test using mouse hepatocytes. , 1989, Mutation research.

[31]  M. Boisset,et al.  Pre- and postweaning development of drug-metabolizing enzyme activities in small intestine and liver of rats. , 1988, Drug Metabolism And Disposition.

[32]  J. Ashby,et al.  A non-invasive micronucleus assay in the rat liver. , 1988, Mutation research.

[33]  J Ashby,et al.  Carcinogen/mutagen screening strategies. , 1986, Mutagenesis.

[34]  A. Tates,et al.  Persistence of preclastogenic damage in hepatocytes of rats exposed to ethylnitrosourea, diethylnitrosamine, dimethylnitrosamine and methyl methanesulphonate. Correlation with DNA O-alkylation. , 1986, Carcinogenesis.

[35]  D J Tweats,et al.  The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens. , 1986, Mutagenesis.

[36]  J. Ashby,et al.  Concomitant observations of UDS in the liver and micronuclei in the bone marrow of rats exposed to cyclophosphamide or 2-acetylaminofluorene. , 1985, Mutation research.

[37]  B. Elliott.  Azoreductase activity of Sprague Dawley and Wistar-derived rats towards both carcinogenic and non-carcinogenic analogues of 4-dimethylaminophenylazobenzene (DAB). , 1984, Carcinogenesis.

[38]  B E Butterworth,et al.  Dinitrotoluene: acute toxicity, oncogenicity, genotoxicity, and metabolism. , 1984, Critical reviews in toxicology.

[39]  A. Tates,et al.  The induction of chromosomal damage in rat hepatocytes and lymphocytes. I. Time-dependent changes of the clastogenic effects of diethylnitrosamine, dimethylnitrosamine and ethyl methanesulfonate. , 1983, Mutation research.

[40]  N. Ozawa,et al.  Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test. , 1982, Mutation research.

[41]  B. Butterworth,et al.  Detection of genotoxic carcinogens in the in vivo-in vitro hepatocyte DNA repair assay. , 1982, Environmental mutagenesis.

[42]  Some antineoplastic and immunosuppressive agents. , 1981, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[43]  M A Kastenbaum,et al.  Tables for determining the statistical significance of mutation frequencies. , 1970, Mutation research.